Human immunodeficiency virus disease: Changing patterns of intraocular inflammation

American Journal of Ophthalmology

Volumn 125, Issue 3, 1998, Pages 374-382

  Nussenblatt, Robert B ^a   Lane, H Clifford ^b  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RIFABUTIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

EYE INFLAMMATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; INTRAOCULAR DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MEDICAL LITERATURE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RETINITIS; REVIEW; TOPICAL DRUG ADMINISTRATION;

EID: 0032032296     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)80149-4     Document Type: Article

References (26)

1. 1. Schuman JS, Friedman AH. Retinal manifestations of the acquired immune deficiency syndrome. Trans Ophthalmol Soc UK 1983;103:177-189.
2. 2. Fujikawa LS, Salahuddin SZ, Palestine AG, Masur H, Nussenblatt RB, Gallo RC. Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. Lancet 1985;2:529-530.
3. 2. Pepose JS, MacRae S, Quinn TC, Ward JW. Serologic markers after the transplantation of corneas from donors infected with human immunodeficiency virus. Am J Ophthalmol 1987;103:798-801.
4. 3. Chakroun M, Meyohas MC, Pelosse B, et al. Ocular toxoplasmosis in AIDS. Ann Med Interne (Paris) 1990;141: 472-474.
5. 4. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992 Jan 23;326:213-220.
6. 5. Collier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus infection with sequinovir, zidovudine, and zalcitabine. N Engl J Med 1996;334:1011-1017.
7. + lymphocyte count improves assessment of antiretroviral therapeutic response. Ann Intern Med 1997;126:929-938.
8. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-149.
9. + T cells in peripheral blood of deoxycoformycin-treated patients. J Nat Cancer Inst 1991;83:1678-1679.
10. 9. Whitcup SM, Fortin E, Muccioli C, Polis MA, Nussenblatt RB, Belfort R Jr. Therapeutic effect of increased CD4 T-cell counts on cytomegalovirus retinitis in patients with AIDS. JAMA 1997;277:1519-1520.
11. 10. Reed JB, Schwab IR, Gordon J, Morse LS. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am J Ophthalmol 1997; 124:199-205.
12. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 1997;3:533-540.
13. 12. Zegans ME, Walton RC, Holland GN, O'Donnell JJ, Jacobson MA, Margolis TP. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1998;25:292-300.
14. 13. Burd EM, Pulido JS, Puro DG, O'Brien WJ. Maintenance of replicative intermediates in ganciclovir-treated human cytomegalovirus-infected retinal glia. Arch Ophthalmol 1996; 114:856-861.
15. 14. Zingman BS. Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir. N Engl J Med 1996;334:1674-1675.
16. 15. Jacobson MA, Zegans M, Pavan PR, et al. Cytomgalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-1445.
17. 16. Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY. Acquired immune deficiency syndrome: pathogenic mechanisms of ocular disease. Ophthalmology 1985;92:472-484.
18. 17. Silverstein BE, Smith JH, Sykes SO, Jones MR, Schwartz D, Cunningham ET Jr. Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1998;25:411-415.
19. 18. Kuo IC, Kapusta MA, Rao NA. Vitritis as the primary manifestation of ocular syphilis in patients with HIV infection. Am J Ophthalmol 1998;25:306-311.
20. 19. Rosberger DF, Heinemann M-H, Freidberg DN, Holland GN. Uveitis associated with human immunodeficiency virus infection. Am J Ophthalmol 1998;25:301-305.
21. 20. Levinson RD, Vann R, Davis JL, et al. Chronic multifocal retinal infiltrates in patients infected with human immunodeficiency virus. Am J Ophthalmol 1998;25:312-324.
22. 21. Davis JL. Human immunodeficiency virus-related uveitis. Curr Opin Ophthalmol 1991;2:471-479.
23. 22. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983;309:453-458.
24. 23. Jarvis JN, Iobidze M, Taylor H, Dejonge J, Chang S. A comparison of immunoglobulin G-containing high-molecular-weight complexes isolated from children with juvenile rheumatoid arthritis and congenital human immunodeficiency virus infection. Pediatr Res 1993;34:781-784.
25. 24. Romani J, Puig L, Baselga E, De Moragas JM. Reiter's syndromelike pattern in AIDS-associated psoriasiform dermatitis. Int J Dermatol 1996;35:484-488.
26. 25. Davis JL, Taskintuna I, Freeman WR, Weinberg DV, Feuer WJ, Leonard RE. Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch Ophthalmol 1997;115:733-737.